Patents by Inventor Robby Weimer

Robby Weimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180222974
    Abstract: The invention provides methods for treating neurological diseases and reducing microglia density using anti-IL-34 antibodies.
    Type: Application
    Filed: November 29, 2017
    Publication date: August 9, 2018
    Applicant: Genentech, Inc.
    Inventors: Courtney EASLEY-NEAL, Robby WEIMER, Ali Akbar ZARRIN
  • Publication number: 20110110942
    Abstract: The invention relates to methods of increasing density of dendritic spines as a means to retain or improve cognition and to treat disorders associated with decreased dendritic spine morphology and a psychiatric disorder such as addiction and schizophrenia or a disorder associated with impaired cognition such as autism, Lett Syndrome, Tourette Syndrome, and Fragile-X Syndrome.
    Type: Application
    Filed: November 12, 2010
    Publication date: May 12, 2011
    Applicant: GENENTECH, INC.
    Inventors: DARA KALLOP, ANATOLY NIKOLAEV, MARC TESSIER-LAVIGNE, ROBBY WEIMER
  • Publication number: 20110064670
    Abstract: The invention provides methods for identifying patients having an increased likelihood of responding to an anti-cancer agent or an increased likelihood of undergoing metastasis. The invention also provides methods for monitoring a patients' response to an anti-cancer agent. The invention also provides kits and articles of manufacture for use in the methods.
    Type: Application
    Filed: September 10, 2010
    Publication date: March 17, 2011
    Applicant: Genentech, Inc.
    Inventors: Alvin Gogineni, Maresa Caunt, Nicholas van Bruggen, Anil D. Bagri, Robby Weimer